rs371528857
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_144687.4(NLRP12):c.1330C>G(p.Gln444Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144687.4 missense
Scores
Clinical Significance
Conservation
Publications
- familial cold autoinflammatory syndrome 2Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NLRP12 | ENST00000324134.11 | c.1330C>G | p.Gln444Glu | missense_variant | Exon 3 of 10 | 1 | NM_144687.4 | ENSP00000319377.6 | ||
| NLRP12 | ENST00000345770.9 | c.1330C>G | p.Gln444Glu | missense_variant | Exon 3 of 9 | 1 | ENSP00000341428.5 | |||
| NLRP12 | ENST00000391772.1 | c.1330C>G | p.Gln444Glu | missense_variant | Exon 3 of 7 | 1 | ENSP00000375652.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152088Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000798 AC: 2AN: 250614 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461364Hom.: 0 Cov.: 40 AF XY: 0.0000110 AC XY: 8AN XY: 726988 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74280 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Familial cold autoinflammatory syndrome 2 Uncertain:2
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 444 of the NLRP12 protein (p.Gln444Glu). This variant is present in population databases (rs371528857, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with NLRP12-related conditions. ClinVar contains an entry for this variant (Variation ID: 536925). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt NLRP12 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1330C>G (p.Q444E) alteration is located in exon 3 (coding exon 3) of the NLRP12 gene. This alteration results from a C to G substitution at nucleotide position 1330, causing the glutamine (Q) at amino acid position 444 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at